Canadian CT Head Rule Age Validation
The Canadian CT Head Rule is validated for patients aged 16 years and older. 1, 2, 1
Age Cutoff and Rationale
The 2021 ACR Appropriateness Criteria explicitly states: "These guidelines are intended for patients who are 16 years of age." 1 This age threshold represents the lower boundary for adult application of the rule.
For patients under 16 years, the Canadian CT Head Rule should not be applied. Instead, pediatric-specific decision tools should be used, particularly the PECARN (Pediatric Emergency Care Applied Research Network) criteria, which have been extensively validated in children and stratify risk by age groups (<2 years and ≥2 years). 3
Original Validation Population
The Canadian CT Head Rule was originally published in 2001 by Stiell et al. 4 The derivation study included 3,121 consecutive adults with:
- Glasgow Coma Scale scores of 13-15
- Mean age of 38.7 years
- Presentation within 24 hours of head injury
The rule demonstrated 100% sensitivity (95% CI 92-100%) for predicting need for neurosurgical intervention using five high-risk factors, and 98.4% sensitivity (95% CI 96-99%) for clinically important brain injury when including two additional medium-risk factors.
Clinical Application Framework
The 2008 ACEP Clinical Policy reinforced this age cutoff, stating the guidelines apply to "patients aged 16 years or greater" with specific inclusion criteria. 2 The policy deliberately excluded pediatric patients because separate evidence-based guidelines exist for that population.
Important Caveats
Upper age considerations: While no upper age limit exists for the rule, recent evidence suggests diminishing utility in very elderly patients (≥75 years), where baseline CT rates approach 98% and risk stratification shows limited capacity to safely reduce imaging. 5, 6
Unclear histories in older adults: The rule was validated in patients with clear histories of loss of consciousness, amnesia, or disorientation. Older adults with unclear fall histories or uncertain head trauma represent a distinct population where the rule's application criteria may not be met, yet they still carry elevated bleeding risk (4.6-7.6%). 7